Activist 13D/13G Filings - Xeris Biopharma Holdings Inc. (XERS)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-02-13
5:17 pm
Purchase
13GXERIS BIOPHARMA HLDGS INC
XERS
VANGUARD GROUP INC7,086,345
5.130%
7,086,345increase
(New Position)
View
2024-02-13
4:34 pm
Sale
13GXERIS BIOPHARMA HLDGS INC
XERS
Stonepine Capital Management LLC5,937,000
4.300%
-5,258,189decrease
(-46.97%)
View
2024-01-26
4:23 pm
Purchase
13GXERIS BIOPHARMA HLDGS INC
XERS
BlackRock Inc.
BLK
10,011,391
7.200%
1,435,178increase
(+16.73%)
View
2023-02-14
12:15 pm
Sale
13GXERIS BIOPHARMA HLDGS INC
XERS
CAXTON CORP5,973,324
4.400%
-1,856,358decrease
(-23.71%)
View
2023-02-13
10:57 am
Purchase
13GXERIS BIOPHARMA HLDGS INC
XERS
Stonepine Capital Management LLC11,195,189
8.200%
4,704,090increase
(+72.47%)
View
2023-02-10
09:04 am
Purchase
13GXERIS BIOPHARMA HLDGS INC
XERS
BlackRock Inc.
BLK
8,576,213
6.300%
8,576,213increase
(New Position)
View
2022-02-11
4:20 pm
Purchase
13GXERIS BIOPHARMA HLDGS INC
XERS
Flynn James E5,882,353
4.500%
5,882,353increase
(New Position)
View
2022-01-13
6:13 pm
Purchase
13GXERIS BIOPHARMA HLDGS INC
XERS
Stonepine Capital Management LLC6,491,099
5.200%
6,491,099increase
(New Position)
View
2022-01-05
12:38 pm
Purchase
13GXERIS BIOPHARMA HLDGS INC
XERS
CAXTON CORP7,829,682
5.700%
7,829,682increase
(New Position)
View